The recent COVID-19 pandemic has brought together several biotech companies from around the world in an unprecedented effort to find a COVID-19 vaccine that would save humanity. The German company Biontech will join forces with the Chinese company Fosun Pharma, which will become a shareholder in the German biotech start-up. Biontech will receive an impressive $129 million (€120 million) for research.
anonymousInvesting March 22, 2020 at 9:48 am
00
Thought Tags
Get Social and Share